Clinical Trial Update: Bioequivalence Study Comparing A New 10 Mg Atorvastatin Tablet To A 10 Mg Atorvastatin Commercial Tablet [Phase 4]

View source ↗

Summary

A phase 4 bioequivalence study compared a new 10 mg atorvastatin tablet to a 10 mg commercial atorvastatin tablet in hypercholesterolemia; study completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2009-10-14